Researchers from the Netherlands Pharmacovigilance Centre Lareb, including several ENTIS members, have published a study comparing infants’ birth defects as reported by mothers and general […]

Researchers from the Netherlands Pharmacovigilance Centre Lareb, including several ENTIS members, have published a study […]
Researchers from the MONEAD investigator group have published the results of a longitudinal study investigating […]
ENTIS members from the Berlin TIS (Embryotox) have published a comparative cohort study investigating pregnancy […]
Researchers affiliated with the Pregnancy Inflammatory bowel disease And Neonatal Outcomes (PIANO) registry have published a […]
Researchers affiliated to The AVONEX® Pregnancy Exposure Registry (Biogen) have published a case series of […]
ENTIS is a global collaborative network of Teratology Information Services. Member organisations consist of medical doctors, pharmacists, genetic counsellors and scientists all working together with the primary aim of preventing birth defects and developmental disorders which arise as a consequence of maternal or paternal perinatal exposures.
ENTIS member organisations work in three core areas:
ENTIS collaborates with researchers from a range of academic, industry and patient representative organisations. If you are interested in working with ENTIS or in joining our network, please contact us.
Alternatively, click here to learn more about ENTIS.
Updates will be released regularly, check the annual meeting page for the latst news
Researchers from the Netherlands Pharmacovigilance Centre Lareb, including several ENTIS members, have published a study comparing infants’ birth defects as reported by mothers and general […]
Researchers from the MONEAD investigator group have published the results of a longitudinal study investigating associations between fetal anti-seizure medication (ASM) exposure and adaptive, behavioural […]
ENTIS members from the Berlin TIS (Embryotox) have published a comparative cohort study investigating pregnancy outcomes for pregnancies exposed to levetiracetam. More information can be […]
Researchers affiliated with the Pregnancy Inflammatory bowel disease And Neonatal Outcomes (PIANO) registry have published a study of pregnancy and infant outcomes following maternal vedolizumab and […]
Researchers affiliated to The AVONEX® Pregnancy Exposure Registry (Biogen) have published a case series of 306 pregnancy outcomes for a cohort of women with multiple […]
See here for the latest announcement about the 2024 joint ENTIS-OTIS meeting in Nyborg, Denmark.
In 2022, the European Society for Medical Oncology held a virtual meeting to gain insights from a multidisciplinary group of experts and develop statements about […]
The Italian Societies of Toxicology, Neuropsychopharmacology, Psychiatry, Obstetrics and Gynecology, Drug Addiction, and Addiction Pathology have published joint consensus recommendations regarding the management of depressive […]